Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 1201 results for "sun pharma"

Sensex, Nifty continue to struggle; HUL, Sun Pharma gain 1%

Reliance, Coal India, ONGC, Adani Ports and HDFC are losers in the Sensex while Axis Bank, HUL, Asain Paints, Sun Pharma and NTPC are gainers. Money Control, 4 hours ago

293 images for sun pharma

Deccan Chronicle, 1 day ago, 1 week ago, 2 weeks ago
Money Control, 1 week ago
Business Today India, 3 weeks ago
Financial Express, 1 week ago
India Infoline, 3 weeks ago, 3 weeks ago
Deccan Chronicle, 3 weeks ago
Money Today, 3 weeks ago

Nifty hovers around 8400, Sensex in red; metals, oil stocks fall

HUL, Axis Bank, Asian Paints, Sun Pharma and TCS are gainers in the Sensex while Reliance, Adani Ports, Lupin, Tata Steel and Coal India are losers in the Sensex.
 Money Control7 hours ago Sensex higher, Midcap corrects; pharma, FMCG, metals stocks slip  Moneycontrol.com5 days ago Nifty ends below 8200, Sensex climbs 260 pts; FMCG gains  Money Control2 weeks ago Sensex, Nifty choppy; Mahindra Mahindra rises, Sun Pharma down  Money Control3 weeks ago
Business Standard

Sun Pharma, Moebius Medical to develop osteoarthritis pain product

Sun PharmaBSE 1.07 % and Israel-based Moebius Medical have entered into an exclusive worldwide licensing deal to further develop MM-II, a novel pharmaceutical candidate for the treatment of pain in osteoarthritis, Sun said in a release to the press.
 Indiaexportnews.com7 hours ago Sun Pharma & Moebius Medical sign exclusive global licensing deal to develop novel liposomal non-opioid pain product for Osteoarthritis  PharmaAsia2 weeks ago Sun Pharma advances after signing exclusive global licensing deal with Moebius Medical  Business Standard1 month ago Sun Pharma to partner with Israel's Moebius Medical for osteoarthritis drug  Business Standard1 month ago

Sun Pharma, NTPC, TCS up by more than 1%; Sensex well above 27000

With the markets undercurrent being bullish and trading comfortably above 27000, Sun Pharma, NTPC, TCS are the top gainers in the first half hour of the trading session by gaining more than 1% each.
 India Infoline8 hours ago
Financial Express

Sensex, Nifty end at over 2-month closing high; IT stocks drag

Tata Steel, Tata Motors, Adani Ports, SBI and Hero MotoCorp are gainers while Infosys, ONGC, Reliance, Sun Pharma and GAIL are losers in the Sensex.
 Money Control1 day ago Sensex, Nifty rangebound; Sun Pharma, Reliance down  Money Control1 day ago Sensex, Nifty end higher; Pharma stocks slide  Business Today India5 days ago Sensex continues strong, but pharma stocks limit gains; Nifty holds above 8,400  Financial Express5 days ago

Sun Pharma Q3 PAT may dip 26.7% to Rs 1638 cr: ICICI Securities

Net Sales are expected to decrease by 2.4 percent Q-o-Q (up 9.8 percent Y-o-Y) to Rs 7773.7 crore, according to ICICI Securities.
 Money Control1 day ago Sun Pharma Q3 PAT may dip 26.2% to Rs 1649.5 cr: KR Choksey  Money Control4 days ago

Pharma barons swallow FDA bitter pill, Sun Pharma's Shanghv biggest loser

Combined net worth of country's top 8 pharma promoters down by Rs 42,000 crore since 2015
 Business Standard1 day ago

Donald Trump's words spook Indian pharma stocks

MUMBAI: United States president-elect Donald Trump's bashing of the pharmaceuticals industry has pushed shares of Indian drug makers down, as a possibility of pricing pressure in their most profitable market looms over these companies. In his ...
 Economic Times4 days ago At Press Conference, Trump Raises Issue of Pharma Overcharging That Could Impact India  India-West3 days ago Indian pharmaceutical sector may take a hit under Trump regime  Oneindia4 days ago Trump's attack on pharma industry won't harm Indian generic drug makers: analysts  Livemint.com4 days ago

Sun Pharma Announces Positive Topline Results of Confirmatory Phase-3 Clinical Trial for

Sun Pharma announced successful Phase 3 confirmatory clinical trial results for Seciera(TM) (cyclosporine A, 0.09% ophthalmic solution), for the treatment of dry eye disease. Seciera(TM) is a patented, novel, proprietary nanomicellar formulation of ...
 Newswit.com6 days ago India's Sun Pharma reports positive topline results of phase-3 clinical trial for Seciera  Pharmaceutical Tech.com1 week ago Sun Pharma rise nearly 2% on successful trial for Seciera  HT Syndication1 week ago Sun Pharma gains after successful clinical trial results of ophthalmic solution  Business Standard1 week ago

Sun Pharma Advanced Research Company to announce Q3 results

On 27 January 2017
 Business Standard6 days ago Sun Pharma Advanced's Q3 results on January 27, 2017  Money Control6 days ago SPARC spikes 7% on USFDA's complete response letter for Xelpros  Money Control3 weeks ago SPARC gains after receiving USFDA's CRL for Xelpros  Business Standard3 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less